Article Versions Notes

Bell SM, Barnes K, De Marco M, Shaw PJ, Ferraiuolo L, Blackburn DJ, Venneri A, Mortiboys H. Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future? Biomedicines. 2021; 9(1):63. https://doi.org/10.3390/biomedicines9010063

Bell, Simon M., Katy Barnes, Matteo De Marco, Pamela J. Shaw, Laura Ferraiuolo, Daniel J. Blackburn, Annalena Venneri, and Heather Mortiboys. 2021. "Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?" Biomedicines 9, no. 1: 63. https://doi.org/10.3390/biomedicines9010063

Bell, S. M., Barnes, K., De Marco, M., Shaw, P. J., Ferraiuolo, L., Blackburn, D. J., Venneri, A., & Mortiboys, H. (2021). Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future? Biomedicines, 9(1), 63. https://doi.org/10.3390/biomedicines9010063